CXCL13 and breast carcinoma: Breast cancer cell lines undergoing CXCL13 stimulation overexpress EMT regulators and MMP9 via the nuclear factor kappa-B ligand (RANKL)-Src pathway, which is critical for breast cancer cell progression and migration [83,130].